Last reviewed · How we verify

NCT02874131

Behavioral Activation + Cognitive Processing Therapy for PTSD and Comorbid MDD

Completed NA Last updated 15 November 2024
What this trial tests

NA trial testing Behavioral Activation in Posttraumatic Stress Disorder in 100 participants. Completed in 18 March 2022.

Timeline
20 October 2015
Primary endpoint
18 March 2022
18 March 2022

Quick facts

Lead sponsorUnited States Naval Medical Center, San Diego
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposetreatment
Enrollment100
Start date20 October 2015
Primary completion18 March 2022
Estimated completion18 March 2022
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

United States Naval Medical Center, San Diego

Who can join

18 and older, any sex, with Posttraumatic Stress Disorder or Major Depressive Disorder. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study is a randomized controlled trial comparing an integrated treatment, Behavioral Activation + Cognitive Processing Therapy (BA + CPT), to CPT alone among active-duty service members with posttraumatic stress disorder (PTSD) and comorbid major depressive disorder (MDD). Participants will complete assessor-administered and self-report measures at pre- and post-treatment assessments, as well as a 3-month follow-up. Additionally, participants will complete self-report measures of PTSD and MDD symptoms at each therapy session.

Publications & conference data

3 peer-reviewed publications reference this trial (live from Europe PMC):

  1. Dropout in a clinical trial for comorbid PTSD and MDD among US service members: Are pretreatment characteristics predictive?
    Kline AC, Otis NP, Norman SB, Hunt WM, et al · · 2025 · cited 2× · PMID 38497740 · DOI 10.1080/10503307.2024.2325519
  2. Sudden gains in cognitive processing therapy with and without behavioral activation among service members with comorbid PTSD and MDD.
    Otis NP, Kline AC, Glassman LH, Michael Hunt W, et al · · 2025 · cited 1× · PMID 40288269 · DOI 10.1016/j.brat.2025.104753
  3. Sex differences in treatment outcomes among U.S. service members with comorbid PTSD and MDD.
    Glassman LH, Otis NP, Kline AC, Hunt WM, et al · · 2026 · PMID 41620779 · DOI 10.1186/s40359-025-03878-4

Verify or expand the search:

Other trials of Behavioral Activation

Trials testing the same drug.

Other recruiting trials for Posttraumatic Stress Disorder

Currently open trials in the same condition.

Other United States Naval Medical Center, San Diego trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02874131.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing